Kolawole EM , McLeod JJ , Ndaw V , et al
Autoimmune conditions: May require lower starting doses and immune-first strategies Multiple injuries: Sequencing may matter more than stacking everything at once Complex medication regimens: Interaction review is essential Severe deconditioning: Foundational rehab may need to precede peptides These cases highlight why clinician guidance matters
Nov-Dec 2022;41(8):796-809
When levels are low, symptoms such as tiredness, weakness, and reduced concentration can occur
Novel inhibitors complexed with glutamate dehydrogenase: allosteric regulation by control of protein dynamics
The recommended protocol rotates all three (PDRN, EGF, GHK-Cu) across sessions so each gets a fresh chamber and the underlying biology of each pathway has time to compound